[Entero-hepatic circulation of bile salts in normal and pathological conditions]

Estimation of the age of the ancestral arginine3500-->glutamine mutation in human apoB-100.

Genomics·1997

Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?

Atherosclerosis·1995

The affinity of low-density lipoproteins and of very-low-density lipoprotein remnants for the low-density lipoprotein receptor in homozygous familial defective apolipoprotein B-100.

Atherosclerosis·1995

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.

Atherosclerosis·1993

The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100.

Atherosclerosis·1993

Variable expression of the mutation in familial defective apolipoprotein B-100.

Arteriosclerosis and thrombosis : a journal of vascular biology·1993

[Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.]

Recenti progressi in medicina·2026

[Use of sacituzumab govitecan in HR+/HER2- metastatic breast cancer following progression on endocrine therapy and chemotherapy: a case report in line with the results of the TROPiCS-02 study.]

Recenti progressi in medicina·2026

[Efficacy and safety of sacituzumab govitecan in patients with metastatic HR+/HER2- pleomorphic lobular breast cancer complicated by renal impairment.]

Recenti progressi in medicina·2026

Adoption, use, and barriers to artificial intelligence and telemedicine in Italian primary care: a cross-sectional national survey.

Recenti progressi in medicina·2026

[Aspettative dei pazienti nei confronti di un sistema informatizzato di supporto decisionale clinico basato sull'intelligenza artificiale per migliorare la continuità delle cure dopo il ricovero ospedaliero: uno studio trasversale sulla riabilitazione dopo la protesi totale dell'anca o del ginocchio per l'osteoartrite, con questionario pilota.]

Recenti progressi in medicina·2026

Offshore clinical research as a crisis of the ethics of knowledge.

Recenti progressi in medicina·2026

Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026

The gut-liver-brain axis in alcohol use disorder: The emerging role of bile acid dysregulation.

Behavioural brain research·2026

Clinical utility of the lipemic index for identifying severe triglyceride-rich lipoprotein disorders in adults undergoing routine blood testing.

Clinica chimica acta; international journal of clinical chemistry·2026

Correction: Locomotor and endocrine alterations link to metabolic dysfunction induced by pathopharmacological interaction between neurodevelopmental disorders and antipsychotics: evidence from clinical and animal study.

Frontiers in psychiatry·2026

SLC25 in intestinal inflammation: mechanisms, pathological roles, and therapeutic implications.

Frontiers in immunology·2026

Open Excision of a Broad-Based Duodenal Lipoma Not Amenable to Endoscopic Resection: A Case Report.

Cureus·2026

Related Experiment Videos

[Entero-hepatic circulation of bile salts in normal and pathological conditions]

Related Concept Videos

Estimation of the age of the ancestral arginine3500-->glutamine mutation in human apoB-100.

Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?

The affinity of low-density lipoproteins and of very-low-density lipoprotein remnants for the low-density lipoprotein receptor in homozygous familial defective apolipoprotein B-100.

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia.

The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100.

Variable expression of the mutation in familial defective apolipoprotein B-100.

[Sacituzumab govitecan in ER+/HER2- breast cancer: a necessary treatment option for patients who have undergone multiple prior treatments.]

[Use of sacituzumab govitecan in HR+/HER2- metastatic breast cancer following progression on endocrine therapy and chemotherapy: a case report in line with the results of the TROPiCS-02 study.]

[Efficacy and safety of sacituzumab govitecan in patients with metastatic HR+/HER2- pleomorphic lobular breast cancer complicated by renal impairment.]

Adoption, use, and barriers to artificial intelligence and telemedicine in Italian primary care: a cross-sectional national survey.

Offshore clinical research as a crisis of the ethics of knowledge.

Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study.

The gut-liver-brain axis in alcohol use disorder: The emerging role of bile acid dysregulation.

Clinical utility of the lipemic index for identifying severe triglyceride-rich lipoprotein disorders in adults undergoing routine blood testing.

Correction: Locomotor and endocrine alterations link to metabolic dysfunction induced by pathopharmacological interaction between neurodevelopmental disorders and antipsychotics: evidence from clinical and animal study.

SLC25 in intestinal inflammation: mechanisms, pathological roles, and therapeutic implications.

Open Excision of a Broad-Based Duodenal Lipoma Not Amenable to Endoscopic Resection: A Case Report.

Related Experiment Videos

[Entero-hepatic circulation of bile salts in normal and pathological conditions]

Related Concept Videos

Related Articles